Brand Name
Phendimetrazine
View Brand InformationFDA approval date: January 01, 1978
Classification: Sympathomimetic Amine Anorectic
Form: Tablet, Capsule
What is Phendimetrazine?
Phendimetrazine tartrate extended-release capsules are indicated in the management of exogenous obesity as a short term adjunct in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index of greater than or equal to 30 kg/m 2 or greater than or equal to 27 kg/m 2 in the presence of other risk factors who have not responded to appropriate weight reducing regimen alone. Below is a chart of Body Mass Index based on various heights and weights. BMI is calculated by taking the patient’s weight, in kilograms , divided by the patient’s height, in meters , squared. Metric conversions are as follows: pounds.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment